Exicure, Inc. financial data

Symbol
XCUR on Nasdaq
Industry
Pharmaceutical Preparations
Location
2430 N. Halsted St., Chicago, Illinois
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Max-1 Acquisition Corp (to 9/28/2017)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 80 % -40.3%
Debt-to-equity 305 % +86%
Return On Equity -288 % -935%
Return On Assets -71.2 % -644%
Operating Margin 23.4 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.65M shares +0.03%
Common Stock, Shares, Outstanding 8.65M shares +0.03%
Entity Public Float 5.8M USD -34.8%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 8.65M shares +2.59%
Weighted Average Number of Shares Outstanding, Diluted 8.65M shares +2.59%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 0 USD -100%
General and Administrative Expense 6.47M USD -51.3%
Operating Income (Loss) -6.89M USD -315%
Nonoperating Income (Expense) -1.29M USD -2048%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.17M USD -350%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -8.17M USD -367%
Earnings Per Share, Basic -0.9 USD/shares -150%
Earnings Per Share, Diluted -0.9 USD/shares -150%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 528K USD -77.4%
Assets, Current 2.08M USD -43.3%
Property, Plant and Equipment, Net 40K USD -97.8%
Operating Lease, Right-of-Use Asset 6.13M USD -11.1%
Other Assets, Noncurrent 2.44M USD -23.7%
Assets 10.7M USD -39.1%
Accounts Payable, Current 1.59M USD +362%
Employee-related Liabilities, Current 0 USD -100%
Accrued Liabilities, Current 846K USD -22.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 3.43M USD +140%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 5.64M USD -12.1%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 9.08M USD +15.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -191M USD -4.47%
Stockholders' Equity Attributable to Parent 1.61M USD -83.4%
Liabilities and Equity 10.7M USD -39.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -450K USD +86.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.65M shares +0.03%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -450K USD -133%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.4M USD -60.4%
Deferred Tax Assets, Valuation Allowance 4.25M USD -90.4%
Operating Lease, Liability 6.67M USD -8.77%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.9M USD -556%
Lessee, Operating Lease, Liability, to be Paid 8.61M USD -12.2%
Property, Plant and Equipment, Gross 279K USD -94.8%
Operating Lease, Liability, Current 671K USD +15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.27M USD +2.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.13M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.95M USD -22.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.31M USD +3.07%
Deferred Tax Assets, Operating Loss Carryforwards 3.15M USD -91.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.35M USD +2.98%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 193M USD +0.04%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 2.15M USD -18.6%
Share-based Payment Arrangement, Expense 82K USD -95.4%
Interest Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%